GSK spin-off Haleon offloads Chapstick brand for £400m to ‘simplify’ business January 25, 2024 Consumer healthcare company Haleon has agreed to sell its Chapstick lip balm brand to Yellow Wood Partners in a deal worth $510m (£401m) as part of efforts to "simplify" its business model.
Haleon: Chinese re-opening powers GSK spin-off to ‘consistent’ growth August 2, 2023 Strong sales of toothpaste and painkillers contributed to healthy results for Haleon, the newly-formed consumer healthcare firm spun out of GSK last year. In the first half of 2023, the Surrey-headquartered company’s revenue increased to £5.7bn, up 10.6 per cent compared to the same period last year. This was driven by Haleon’s ‘power brands’, such [...]
Haleon: Flu season and Chinese pain relief give GSK spin-out a boost May 3, 2023 A “strong” cold and flu season and the end of Chinese lockdowns contributed to a healthy revenue boost for Haleon, the spin-out of GSK’s consumer healthcare division. Organic revenues within the group were up 9.9 per cent, with operating profit hitting £627m – reflecting a large reduction in the costs of spinning out the business [...]
GSK brings in zosta lot more cash as drugs giant’s turnover boosted by shingles vaccine and HIV medicines April 26, 2023 Drugs giant GSK has posted better-than-forecast revenues for the first quarter thanks to strong sales of its shingles vaccine and HIV medicines. The FTSE 100 group saw earnings fall 15 per cent on a constant currency basis to £2.1bn in the first quarter as revenues dropped eight per cent to £7bn after sales of its Covid-19 treatment [...]